HealthTech Pioneer Salus Secures $4.7 Million for Advancing Preventive Healthcare Initiatives. ⚕️💰
Salus, a Turkish health initiative, has recently secured a substantial $4.7 million investment in a funding round led by Northzone. Notable contributors include 500 Emerging Europe, Pitch Drive, İş Bankası 100. Yıl Girişim Sermayesi, and individual investors like Adam Anders, Can Yücaoğlu, Mehmet Yılmaz, Joshua Cornelius, and Kıvanç Semen.
User-Centric Approach:
Salus prioritizes user needs, aiming to build a comprehensive preventive healthcare ecosystem.
Diverse Investor Base:
The funding round includes contributions from 500 Emerging Europe, Pitch Drive, İş Bankası 100. Yıl Girişim Sermayesi, and individual angel investors, totaling $4.7 million.
Growing Investor Confidence:
Existing investors, Collective Spark and Wamda Capital, increased their investment, reflecting growing confidence in Salus.
Impressive Team Expansion:
Salus boasts a team of over 200 experts, including clinical psychologists, dietitians, physiotherapists, birth coaches, family counselors, and child development specialists.
Strategic Usage of Funds:
Salus plans to use the funds to support both corporate and individual growth, expanding its product and service offerings to become Turkey's most inclusive health application.
Milestone Achievement:
Within 18 months, Salus has gained attention, serving leading companies like QNB Finansbank, ING, P&G, Midas, Zeplin, Sigortam.net, Ödeal, and more.
Landmark Seed Investment:
With this recent investment, Salus' total funding stands at $5.5 million, marking one of Turkey's largest seed investments.
In Summary:
Salus CEO Alperen Adikti expresses excitement about the journey ahead, emphasizing their commitment to facilitating long-term health and well-being for users. The funds will be instrumental in expanding Salus' services and products, marking Northzone's first investment in Turkey and positioning Salus as a pioneer in the country's health tech landscape.
